Andere Sprachen Chugai Pharmaceutical Co., Ltd

Aktien

857216

JP3519400000

4519

Markt geschlossen - Japan Exchange Andere Börsenplätze 08:00:00 10.05.2024			% 5 Tage	% 1. Jan.
4.946 ^JPY	+0,45 %		-2,91 %	-7,41 %

07.05.	Galderma Group AG: Potenzial in der Hautpflege
25.04.	Muttergesellschaft von Chugai Pharmaceutical, Roche, verzeichnet geringere Verkäufe in Q1; Aktie fällt um 5%	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Galderma Group AG: groot potentieel?	09.05.
Chugai, NCCH, OMPU and MICIN Start Company-Sponsored Phase I Study in Oncology with a New Decentralized Clinical Trial Structure, Improving access to the clinical trial for patients far from the institution	09.05.
Galderma, un grande potenziale?	08.05.
Galderma Group AG: ¿Un gran potencial?	07.05.
Galderma, gros peautentiel ?	07.05.
Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation	01.05.
Chugai Pharmaceutical : Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan	26.04.
Chugai Announces 2024 1st Quarter Results	25.04.
Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%	25.04.
Chugai Pharmaceutical's Profit Slightly Up in Q1	24.04.
Chugai Pharmaceutical : Q1 Results (Jan-Mar 2024)	24.04.
Chugai Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending December 31, 2024; Provides Dividend Guidance for the Year Ending December 31, 2024	24.04.
Chugai Pharmaceutical : F. Hoffmann-La Roche Announces First Quarter Sales 2024	24.04.
Chugai Pharmaceutical Co., Ltd. - Positive Phase III Results Showed Vabysmo Improved Vision for the First Time in Japanese in Angioid Streaks	15.04.
Chugai Pharmaceutical Co., Ltd. - Relief Efforts Support for Earthquake off the Eastern Coast of Taiwan	10.04.
Japan's Nikkei slips on caution ahead of US inflation data	10.04.
Chugai Pharmaceutical to Allocate 594 Million Yen of Treasury Shares as Restricted Stock Compensation	29.03.
Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for the AKT Inhibitor, Capivasertib for Advanced HR-positive, HER2-negative Breast Cancer	28.03.
Chugai Pharmaceutical : Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan	28.03.
Chugai Obtains Regulatory Approval for Vabysmo, the Only Bispecific Antibody in the Ophthalmology Field, for Additional Indication of Macular Edema Associated with Retinal Vein Occlusion	27.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Chugai Pharmaceutical Co., Ltd

Aktien

857216

JP3519400000

4519

Andere Sprachen

Filter